The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2

International Journal of Gynecology and Obstetrics

Volumn 134, Issue 1, 2016, Pages 45-48

  Miyamoto, Shingo ^a   Hasegawa, Junichi ^a   Morioka, Miki ^a   Hirota, Yuko ^a   Kushima, Miki ^a   Sekizawa, Akihiko ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical intraepithelial neoplasia; Grade 2; Immunohistostaining; Ki 67; p16

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16; CYCLIN DEPENDENT KINASE INHIBITOR 2A; P16 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER REGRESSION; CANCER SURGERY; COLPOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK FACTOR; UNIVERSITY HOSPITAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; CANCER GRADING; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE COURSE; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; UTERINE CERVICAL NEOPLASMS;

ADULT; BIOMARKERS, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84971669604     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2015.12.005     Document Type: Article

References (25)

1. A. Oki Identification of high-risk CIN 1/2 and its management based on a large scale cohort study of CIN 1/2 in Japan Acta Obstet Gynaecol Jpn 58 11 2006 1739 1744
2. A.G. Ostor Natural history of cervical intraepitherial neoplasia: a critical review Int J Gynecol Pathol 12 2 1993 186 192
3. P. Holowaty, A.B. Miller, T. Rohan, and To T Natural history of dysplasia of the uterine cervix J Natl Cancer Inst 91 3 1999 252 258
4. K. Matsumoto, A. Oki, R. Furuta, H. Maeda, T. Yasugi, N. Takatsuka, and et al. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study Int J Cancer 128 12 2011 2898 2910
5. M. Schiffman, and N. Wentzensen From human papillomavirus to cervical cancer Obstet Gynecol 116 1 2010 177 185
6. S.K. Kjaer, K. Frederiksen, C. Munk, and T. Iftner Long-term absolute risk of cervical intraepitherial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence J Natl Cancer Inst 102 19 2010 1478 1488
7. J. Heymans, I.H. Benoy, W. Poppe, and C.E. Depuydt Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation Int J Cancer 129 4 2011 903 909
8. A.C. Rodríguez, M. Schiffman, R. Herrero, S. Wacholder, A. Hildesheim, P.E. Castle, and et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections J Natl Cancer Inst 100 7 2008 513 517
9. S. Ortega, M. Malumbres, and M. Barbacid Cyclin D-dependent kinases, INK4 inhibitors and cancer Biochim Biophys Acta 1602 1 2002 73 87
10. M.E. McLaughlin-Drubin, C.P. Crum, and K. Münger Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming Proc Natl Acad Sci U S A 108 5 2011 2130 2135
11. M. Indinnimeo, C. Cicchini, A. Stazi, M.R. Limiti, C. Ghini, P. Mingazzini, and et al. Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma J Exp Clin Cancer Res 19 4 2000 471 475
12. A.J. Kruse, J.P. Baak, E.A. Janssen, M.G. Bol, K.H. Kjellevold, B. Fianne, and et al. Low- and high-risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki67 immuno-quantitative variables J Pathol 199 4 2003 462 470
13. F. Sari Aslani, A. Safaei, M. Pourjabali, and M. Momtahan Evaluation of Ki67, p16 and CK17 markers in differentiating cervical intraepithelial neoplasia and benign lesions Iran J Med Sci 38 1 2013 15 21
14. A.E. Walts, and S. Bose P16/Ki-67 Immunostaining is useful in stratification of atypical metaplastic epithelium of the cervix Clin Med Pathol 1 2008 35 42
15. E.J. Nam, J.W. Kim, J.W. Hong, H.S. Jang, S.Y. Lee, S.Y. Jang, and et al. Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection J Gynecol Oncol 19 3 2008 162 168
16. M. Omori, A. Hashi, K. Nakazawa, T. Yuminamochi, T. Yamane, S. Hirata, and et al. Estimation of prognoses for cervical intraepithelial neoplasia 2 by p16INK4a immunoexpression and high-risk HPV in situ hybridization signal types Am J Clin Pathol 128 2 2007 208 217
17. S. Nishio, T. Fujii, H. Nishio, K. Kameyama, M. Saito, T. Iwata, and et al. P16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping J Gynecol Oncol 24 3 2013 215 221
18. G. Negri, F. Vittadello, F. Romano, A. Kasal, F. Rivasi, S. Girlando, and et al. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri Virchows Arch 445 6 2004 616 620
19. M.T. Galgano, P.E. Castle, K.A. Atkins, W.K. Brix, S.R. Nassau, and M.H. Stoler Using biomarkers as objective standards in the diagnosis of cervical biopsies Am J Surg Pathol 34 8 2010 1077 1087
20. S. Zanotti, A. Fisseler-Eckhoff, and H.G. Mannhez Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma Gynecol Oncol 89 3 2003 376 384
21. S.N. Agoff, P. Lin, J. Morihara, C. Mao, N.B. Kiviat, and L.A. Koutsky p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types Mod Pathol 16 7 2003 665 673
22. M. Lorenzato, S. Caudroy, C. Bronner, G. Evrard, M. Simon, A. Durlach, and et al. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol 36 10 2005 1101 1107
23. W. Al-Saleh, P. Delvenne, R. Greimers, V. Fridman, J. Doyen, J. Boniver, and et al. Assessment of Ki-67 antigen immunostaining in squamous intra-epithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus Am J Clin Pathol 104 2 1995 154 160
24. A.J. Kruse, J.P. Baak, E.A. Janssen, K.H. Kjellevold, B. Fiane, K. Lovslett, and et al. Ki67 predicts progression in early CIN: validation of a multivariate progression risk model Cell Oncol 26 1-2 2004 13 20
25. K.D. Quint, M.N. de Koning, W.G. Quint, E.C. Pirog, and et al. Progression of cervical low grade squamous intraepithelial lesions: in search of prognostic biomarkers Eur J Obstet Gynecol Reprod Biol 170 2 2013 501 506